Waldencast plc
WALD

$409.11 M
Marketcap
$3.65
Share price
Country
$0.03
Change (1 day)
$11.72
Year High
$2.41
Year Low

Waldencast Acquisition Corp. a skin care company, provides advanced skin care treatments. Its products are designed to help minimize the appearance of premature skin aging, skin damage, hyperpigmentation, acne, and sun damage primarily available through dermatologists, plastic surgeons, medical spas, and other skin care professionals. Its portfolio includes Obagi Medical that provides transformational skin care products formulated to minimize signs of skin aging, address dark spots, hyperpigmentation, fine lines, and wrinkles and to protect and enhance skin tone and texture; and Obagi Clinical that offers skin care products designed to prevent the early signs of skin aging. The company was founded in 1988 and is based in White Plains, New York.

marketcap

P/E ratio for Waldencast plc (WALD)

P/E ratio as of 2024: -12.31

According to Waldencast plc's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is -12.31. At the end of 2023 the company had a P/E ratio of -8.37.

P/E ratio history for Waldencast plc from 2021 to 2024

PE ratio at the end of each year

Year P/E ratio
2024 -12.31
2023 -8.37
2022 -22.22
2021 -48.54